The COVID-19 pandemic has thrown a wrench in the works for many pharmaceutical and clinical trial industry events. Organizers of the currently underway CPhI Festival of Pharma shifted their program to fully digital, with keynote addresses, presentations and exhibitor meetups accessible online.
Next year, organizers of the CPhI and Pharmapack Europe events are aiming for a combo platter of formats, with live, digital and hybrid programming on its calendar.
CPhI China—scheduled December 16-18 2020—will be a hybrid event, combining in-person and virtual programming. Producers plan to bring the 2021 events back in full, enhanced with digital elements to help provide broader networking and learning opportunities.
“We are thrilled about coming together with the pharma community again at CPhI Festival of Pharma, and we wanted to give details of all our pharma events for the year ahead. In 2021 we are implementing a hybrid model of events delivery, with virtual and online offerings, as well as live editions to provide greater flexibility to pharma companies and executives,” commented group director Adam Andersen.
Organizers have announced the following dates for its events starting in December and going throughout 2021:
- CPhI China: December 16-18
- CPhI India: January 27-29
- CPhI Japan: April 14-16
- Pharmapack Europe: May 19-20
- CPhI China: June 22-24
- CPhI SEA: August 4-6
- CPhI North America: August 10-12
- CPhI Worldwide: August 31-September 2
- SPhI MEA: September 26-28
- CPhI Korea: October 11-13
- CPhI India: November 24-26
Organizers reportedly are collaborating with local authorities to ensure appropriate safety measures are taken.
“Over the last 31 years, CPhI has created a unique platform to unite specialist communities dedicated to improving healthcare; we provide a place where professionals can meet, exchange knowledge and do business,” Andersen said. “But it’s the real-world impact of their work that inspires us to continually adapt our offering to meet their needs, so while our events are tailored to regional requirements, their reach and significance to patients is truly global.”